Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease.

Jones FE, Murray LS, McNeilly S, Dean A, Aman A, Lu Y, Nikolova N, Malomgré R, Horsburgh K, Holmes WM, Kadler KE, Van Agtmael T.

Hum Mol Genet. 2019 Feb 15;28(4):628-638. doi: 10.1093/hmg/ddy369.

2.

The Chemical Chaperone, PBA, Reduces ER Stress and Autophagy and Increases Collagen IV α5 Expression in Cultured Fibroblasts From Men With X-Linked Alport Syndrome and Missense Mutations.

Wang D, Mohammad M, Wang Y, Tan R, Murray LS, Ricardo S, Dagher H, van Agtmael T, Savige J.

Kidney Int Rep. 2017 Mar 27;2(4):739-748. doi: 10.1016/j.ekir.2017.03.004. eCollection 2017 Jul.

3.

ER stress and basement membrane defects combine to cause glomerular and tubular renal disease resulting from Col4a1 mutations in mice.

Jones FE, Bailey MA, Murray LS, Lu Y, McNeilly S, Schlötzer-Schrehardt U, Lennon R, Sado Y, Brownstein DG, Mullins JJ, Kadler KE, Van Agtmael T.

Dis Model Mech. 2016 Feb;9(2):165-76. doi: 10.1242/dmm.021741.

4.

Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke.

Murray LS, Lu Y, Taggart A, Van Regemorter N, Vilain C, Abramowicz M, Kadler KE, Van Agtmael T.

Hum Mol Genet. 2014 Jan 15;23(2):283-92. doi: 10.1093/hmg/ddt418. Epub 2013 Sep 2.

5.

The neuroinflammatory response in humans after traumatic brain injury.

Smith C, Gentleman SM, Leclercq PD, Murray LS, Griffin WS, Graham DI, Nicoll JA.

Neuropathol Appl Neurobiol. 2013 Oct;39(6):654-66. doi: 10.1111/nan.12008.

6.

Spreading depolarisations and outcome after traumatic brain injury: a prospective observational study.

Hartings JA, Bullock MR, Okonkwo DO, Murray LS, Murray GD, Fabricius M, Maas AI, Woitzik J, Sakowitz O, Mathern B, Roozenbeek B, Lingsma H, Dreier JP, Puccio AM, Shutter LA, Pahl C, Strong AJ; Co-Operative Study on Brain Injury Depolarisations.

Lancet Neurol. 2011 Dec;10(12):1058-64. doi: 10.1016/S1474-4422(11)70243-5. Epub 2011 Nov 3.

PMID:
22056157
7.

Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results.

Moss JG, Cooper KG, Khaund A, Murray LS, Murray GD, Wu O, Craig LE, Lumsden MA.

BJOG. 2011 Jul;118(8):936-44. doi: 10.1111/j.1471-0528.2011.02952.x. Epub 2011 Apr 12.

8.

Neuropathological findings in disabled survivors of a head injury.

Adams JH, Jennett B, Murray LS, Teasdale GM, Gennarelli TA, Graham DI.

J Neurotrauma. 2011 May;28(5):701-9. doi: 10.1089/neu.2010.1733.

PMID:
21401319
9.

The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids.

Rashid S, Khaund A, Murray LS, Moss JG, Cooper K, Lyons D, Murray GD, Lumsden MA.

BJOG. 2010 Jul;117(8):985-9. doi: 10.1111/j.1471-0528.2010.02579.x. Epub 2010 May 11.

10.

Comparison of the efficacy of candesartan and losartan: a meta-analysis of trials in the treatment of hypertension.

Meredith PA, Murray LS, McInnes GT.

J Hum Hypertens. 2010 Aug;24(8):525-31. doi: 10.1038/jhh.2009.99. Epub 2009 Dec 17.

PMID:
20016523
11.

Critical lower-limb ischemia: the diagnostic performance of dual-phase injection MR angiography (including high-resolution distal imaging) compared with digital subtraction angiography.

Owen AR, Robertson IR, Annamalai G, Roditi GH, Edwards RD, Murray LS, Moss JG.

J Vasc Interv Radiol. 2009 Feb;20(2):165-72. doi: 10.1016/j.jvir.2008.10.014. Epub 2008 Dec 10.

PMID:
19081736
12.

The relationships between initial blood pressure and the response to different antihypertensive agents.

Meredith PA, Murray LS, McInnes GT.

J Hypertens. 2007 Dec;25(12):2513-4; author reply 2514. No abstract available.

PMID:
17984676
13.

Are portable bladder scanning and real-time ultrasound accurate measures of bladder volume in postnatal women?

Mathew S, Horne AW, Murray LS, Tydeman G, McKinley CA.

J Obstet Gynaecol. 2007 Aug;27(6):564-7.

PMID:
17896250
14.

Uterine-artery embolization versus surgery for symptomatic uterine fibroids.

Edwards RD, Moss JG, Lumsden MA, Wu O, Murray LS, Twaddle S, Murray GD; Committee of the Randomized Trial of Embolization versus Surgical Treatment for Fibroids.

N Engl J Med. 2007 Jan 25;356(4):360-70.

15.

Endoscopy has minimal impact on mortality from upper gastrointestinal cancer in patients older than 55 years with uncomplicated dyspepsia.

Casburn-Jones AC, Murray LS, Gillen D, McColl KE.

Eur J Gastroenterol Hepatol. 2006 Jun;18(6):645-8.

PMID:
16702854
16.

Association of APOE e4 and cerebrovascular pathology in traumatic brain injury.

Smith C, Graham DI, Murray LS, Stewart J, Nicoll JA.

J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):363-6.

17.

Neuropathology of the vegetative state after head injury.

Graham DI, Adams JH, Murray LS, Jennett B.

Neuropsychol Rehabil. 2005 Jul-Sep;15(3-4):198-213.

PMID:
16350963
18.

Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score.

Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy NC, Fisher NC, Singhal S, Brind A, Haydon G, O'Grady J, Day CP, Hayes PC, Murray LS, Morris AJ.

Gut. 2005 Aug;54(8):1174-9.

19.

Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype.

Leclercq PD, Murray LS, Smith C, Graham DI, Nicoll JA, Gentleman SM.

J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):229-33.

20.

A putative placebo comparison of the SCOPE and LIFE trials.

Meredith PA, Murray LS, McMurray JJ; SCOPE trial; LIFE trial.

J Renin Angiotensin Aldosterone Syst. 2004 Jun;5(2):59-63.

PMID:
15295716
21.

Involvement of apolipoprotein E in glioblastoma: immunohistochemistry and clinical outcome.

Nicoll JA, Zunarelli E, Rampling R, Murray LS, Papanastassiou V, Stewart J.

Neuroreport. 2003 Oct 27;14(15):1923-6.

PMID:
14561921
22.

Tau immunohistochemistry in acute brain injury.

Smith C, Graham DI, Murray LS, Nicoll JA.

Neuropathol Appl Neurobiol. 2003 Oct;29(5):496-502.

PMID:
14507341
23.

Simple morphometry of axonal swellings cannot be used in isolation for dating lesions after traumatic brain injury.

Leclercq PD, Stephenson MS, Murray LS, McIntosh TK, Graham DI, Gentleman SM.

J Neurotrauma. 2002 Oct;19(10):1183-92.

PMID:
12427327
24.

Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia.

McColl KE, Murray LS, Gillen D, Walker A, Wirz A, Fletcher J, Mowat C, Henry E, Kelman A, Dickson A.

BMJ. 2002 Apr 27;324(7344):999-1002. Erratum in: BMJ 2002 Aug 31;325(7362):479. BMJ 2002 Sep 14;325(7364):580.

25.

Testing for Helicobacter pylori in dyspeptic patients. Authors' strategy would leave many patients with ulcer uncured.

McColl KE, Murray LS.

BMJ. 2001 Nov 3;323(7320):1067; author reply 1067-8. No abstract available.

PMID:
11713744
26.

Involvement of apolipoprotein E in herpes simplex encephalitis.

Nicoll JA, Martin L, Stewart J, Murray LS, Love S, Kennedy PG.

Neuroreport. 2001 Mar 26;12(4):695-8.

PMID:
11277566
27.

Neuropathology in vegetative and severely disabled patients after head injury.

Jennett B, Adams JH, Murray LS, Graham DI.

Neurology. 2001 Feb 27;56(4):486-90.

PMID:
11222792
28.

Association of interleukin-1 gene polymorphisms with Alzheimer's disease.

Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, Esiri MM, Murray LS, Dewar D, Love S, Moss T, Griffin WS.

Ann Neurol. 2000 Mar;47(3):365-8.

29.

Head injuries in four British neurosurgical centres.

Murray LS, Teasdale GM, Murray GD, Miller DJ, Pickard JD, Shaw MD.

Br J Neurosurg. 1999 Dec;13(6):564-9.

PMID:
10715724
30.

The neuropathology of the vegetative state after head injury.

Adams JH, Jennett B, McLellan DR, Murray LS, Graham DI.

J Clin Pathol. 1999 Nov;52(11):804-6. No abstract available.

31.

Forearm plethysmography: does the right arm know what the left is doing?

Petrie JR, Perry C, Cleland SJ, Murray LS, Elliott HL, Connell JM.

Clin Sci (Lond). 2000 Feb;98(2):209-10. No abstract available.

PMID:
10657277
32.

Omeprazole and accelerated onset of atrophic gastritis.

McColl KE, Murray LS, Gillen D.

Gastroenterology. 2000 Jan;118(1):239. No abstract available.

PMID:
10644181
33.

Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori.

El-Omar EM, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D, Williams C, Fullarton G, McColl KE.

Gastroenterology. 2000 Jan;118(1):22-30.

PMID:
10611150
34.

Glasgow head injury outcome prediction program: an independent assessment.

Nissen JJ, Jones PA, Signorini DF, Murray LS, Teasdale GM, Miller JD.

J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):796-9.

35.

Changes in systolic time intervals-a non-invasive marker for the haemodynamic effects of sumatriptan.

Hood S, Birnie D, Murray LS, MacIntyre PD, Hillis WS.

Br J Clin Pharmacol. 1999 Sep;48(3):331-5.

36.

Population pharmacokinetics in phase I drug development: a phase I study of PK1 in patients with solid tumours.

Thomson AH, Vasey PA, Murray LS, Cassidy J, Fraier D, Frigerio E, Twelves C.

Br J Cancer. 1999 Sep;81(1):99-107.

37.

Is cancer related to hypertension or to its treatment?

Lever AF, Hole DJ, Gillis CR, McInnes GT, Meredith PA, Murray LS, Reid JL.

Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):937-46. Review.

PMID:
10423115
38.

Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why?

Lever AF, Beevers DG, Hole DJ, Isles CG, Meredith PA, Murray LS, McInnes GT, Reid JL.

Clin Exp Hypertens. 1999 Jul-Aug;21(5-6):553-62.

PMID:
10423081
39.

Effects of subcutaneous naratriptan on systemic and pulmonary haemodynamics and coronary artery diameter in humans.

Hood S, Birnie D, Swan L, Murray LS, Whitehouse H, Winter P, Hillis WS.

J Cardiovasc Pharmacol. 1999 Jul;34(1):89-94.

PMID:
10413073
40.

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

Vasey PA, Kaye SB, Morrison R, Twelves C, Wilson P, Duncan R, Thomson AH, Murray LS, Hilditch TE, Murray T, Burtles S, Fraier D, Frigerio E, Cassidy J.

Clin Cancer Res. 1999 Jan;5(1):83-94.

41.

Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?

Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Reid JL, Robertson JW.

Lancet. 1998 Jul 18;352(9123):179-84.

PMID:
9683206
42.

Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.

McColl KE, el-Nujumi A, Murray LS, el-Omar EM, Dickson A, Kelman AW, Hilditch TE.

Gut. 1998 May;42(5):618-22.

43.

Pre-operative echocardiographic abnormalities and adverse outcome following renal transplantation.

McGregor E, Jardine AG, Murray LS, Dargie HJ, Rodger RS, Junor BJ, McMillan MA, Briggs JD.

Nephrol Dial Transplant. 1998 Jun;13(6):1499-505.

PMID:
9641182
44.

The effect of cimetidine on the pharmacokinetics of epirubicin in patients with advanced breast cancer: preliminary evidence of a potentially common drug interaction.

Murray LS, Jodrell DI, Morrison JG, Cook A, Kerr DJ, Whiting B, Kaye SB, Cassidy J.

Clin Oncol (R Coll Radiol). 1998;10(1):35-8.

PMID:
9543613
45.

Cancer risk of hypertensive patients taking calcium antagonists.

Hole DJ, Gillis CR, McCallum IR, McInnes GT, MacKinnon PL, Meredith PA, Murray LS, Robertson JW, Lever AF.

J Hypertens. 1998 Jan;16(1):119-24.

PMID:
9533425
46.

How reproducible is bilateral forearm plethysmography?

Petrie JR, Ueda S, Morris AD, Murray LS, Elliott HL, Connell JM.

Br J Clin Pharmacol. 1998 Feb;45(2):131-9.

47.
48.

Multicentre phase II pharmacological evaluation of rhizoxin. Eortc early clinical studies (ECSG)/pharmacology and molecular mechanisms (PAMM) groups.

McLeod HL, Murray LS, Wanders J, Setanoians A, Graham MA, Pavlidis N, Heinrich B, ten Bokkel Huinink WW, Wagener DJ, Aamdal S, Verweij J.

Br J Cancer. 1996 Dec;74(12):1944-8.

49.

A comparison of methods for limited-sampling strategy design using data from a phase I trial of the anthrapyrazole DuP-941.

Jodrell DI, Murray LS, Hawtof J, Graham MA, Egorin MJ.

Cancer Chemother Pharmacol. 1996;37(4):356-62.

PMID:
8548882
50.

Bolus/infusional 5-fluorouracil and folinic acid for metastatic colorectal carcinoma: are suboptimal dosages being used in the UK?

Jodrell DI, Murray LS, Reed NS, Canney PA, Kaye SB, Cassidy J.

Br J Cancer. 1994 Oct;70(4):749-52.

Supplemental Content

Loading ...
Support Center